Is there a link between obesity phenotype and thyroid diseases? A mini-review of current concepts
References
- [Anonymous]. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995; 854: 1–452
- [Anonymous]. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res 1998; 6 Suppl 2: 51S–209S
- Snitker S. Use of body fatness cutoff points. Mayo Clin Proc 2010; 85: 1057; author reply 1057–1058
- Collaboration NCDRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 2017; 390: 2627–2642
- Garvey WT, Mechanick JI, Brett EM et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract 2016; 22 Suppl 3: 1–203
- Wharton S, Lau DCW, Vallis M et al. Obesity in adults: a clinical practice guideline. CMAJ 2020; 192: E875–E891
- Milewska EM, Szczepanek-Parulska E, Marciniak M et al. Selected organ and endocrine complications according to BMI and the metabolic category of obesity: A single Endocrine Center Study. Nutrients 2022; 14:
- Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640–1645
- Lavie CJ, Laddu D, Arena R et al. Healthy Weight and Obesity Prevention: JACC Health Promotion Series. Journal of the American College of Cardiology 2018; 72: 1506–1531
- Mongraw-Chaffin M, Foster MC, Anderson CAM et al. Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular Risk. Journal of the American College of Cardiology 2018; 71: 1857–1865
- Lin H, Zhang L, Zheng R et al. The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: A PRISMA-compliant article. Medicine (Baltimore) 2017; 96: e8838
- Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Annals of internal medicine 2013; 159: 758–769
- Fontenelle LC, Feitosa MM, Severo JS et al. Thyroid Function in Human Obesity: Underlying Mechanisms. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2016; 48: 787–794
- Song RH, Wang B, Yao QM et al. The Impact of Obesity on Thyroid Autoimmunity and Dysfunction: A Systematic Review and Meta-Analysis. Front Immunol 2019; 10: 2349
- Santini F, Marzullo P, Rotondi M et al. Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. Eur J Endocrinol 2014; 171: R137–152
- Marzullo P, Minocci A, Tagliaferri MA et al. Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants. J Clin Endocrinol Metab 2010; 95: 3965–3972
- Ayturk S, Gursoy A, Kut A et al. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol 2009; 161: 599–605
- Siqueira RA, Noll M, Rodrigues APS et al. Factors Associated with the Occurrence of Thyroid Nodules in Severely Obese Patients: A Case-Control Study. Asian Pac J Cancer Prev 2019; 20: 693–697
- Buscemi S, Massenti FM, Vasto S et al. Association of obesity and diabetes with thyroid nodules. Endocrine 2018; 60: 339–347
- Harikrishna A, Ishak A, Ellinides A et al. The impact of obesity and insulin resistance on thyroid cancer: A systematic review. Maturitas 2019; 125: 45–49
- Schmid D, Ricci C, Behrens G et al. Adiposity and risk of thyroid cancer: a systematic review and meta-analysis. Obes Rev 2015; 16: 1042–1054
- Lautenbach A, Wernecke M, Mann O et al. Thyroid-stimulating hormone levels in euthyroid patients 8 years following bariatric surgery. Int J Obes (Lond) 2022; 46: 825–830
- van Hulsteijn LT, Pasquali R, Casanueva F et al. Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis. Eur J Endocrinol 2020; 182: 11–21
- Pasquali R, Casanueva F, Haluzik M et al. European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity. Eur J Endocrinol 2020; 182: G1–G32
- Szczepanek-Parulska E, Sokolowski J, Dmowska D et al. Lipid profile abnormalities associated with endocrine disorders. Endokrynol Pol 2022; DOI: 10.5603/EP.a2022.0059:
- Lopez M, Alvarez CV, Nogueiras R et al. Energy balance regulation by thyroid hormones at central level. Trends Mol Med 2013; 19: 418–427
- Coppola A, Liu ZW, Andrews ZB et al. A central thermogenic-like mechanism in feeding regulation: an interplay between arcuate nucleus T3 and UCP2. Cell Metab 2007; 5: 21–33
- Weiner J, Kranz M, Kloting N et al. Thyroid hormone status defines brown adipose tissue activity and browning of white adipose tissues in mice. Sci Rep 2016; 6: 38124
- Guzik TJ, Skiba DS, Touyz RM et al. The role of infiltrating immune cells in dysfunctional adipose tissue. Cardiovasc Res 2017; 113: 1009–1023
- Maurizi G, Della Guardia L, Maurizi A et al. Adipocytes properties and crosstalk with immune system in obesity-related inflammation. J Cell Physiol 2018; 233: 88–97
- Cao H. Adipocytokines in obesity and metabolic disease. J Endocrinol 2014; 220: T47–59
- Haider DG, Schaller G, Kapiotis S et al. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006; 49: 1909–1914
- Silswal N, Singh AK, Aruna B et al. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 2005; 334: 1092–1101
- Longhi S, Radetti G. Thyroid function and obesity. J Clin Res Pediatr Endocrinol 2013; 5 Suppl 1: 40–44
- Pekary AE, Levin SR, Johnson DG et al. Tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta 1 (TGF-beta 1) inhibit the expression and activity of Na+/K(+)-ATPase in FRTL-5 rat thyroid cells. J Interferon Cytokine Res 1997; 17: 185–195
- Kwakkel J, Surovtseva OV, de Vries EM et al. A novel role for the thyroid hormone-activating enzyme type 2 deiodinase in the inflammatory response of macrophages. Endocrinology 2014; 155: 2725–2734
- Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982; 54: 254–260.
- Chen YC, Jiao Y, Cui Y et al. Aberrant brain functional connectivity related to insulin resistance in type 2 diabetes: a resting-state fMRI study. Diabetes Care 2014; 37: 1689–1696
- Zeyda M, Stulnig TM. Obesity, inflammation, and insulin resistance--a mini-review. Gerontology 2009; 55: 379–386
- Griffin ME, Marcucci MJ, Cline GW et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999; 48: 1270–1274
- Matulewicz N, Karczewska-Kupczewska M. Insulin resistance and chronic inflammation. Postepy Hig Med Dosw (Online). 2016; 70: 1245–1258.
- Petersen MC, Shulman GI. Mechanisms of Insulin Action and Insulin Resistance. Physiol Rev. 2018; 98: 2133–2223
- Jornayvaz FR, Samuel VT, Shulman GI. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. Annu Rev Nutr. 2010; 30: 273–290.
- Sakurai Y, Kubota N, Yamauchi T, Kadowaki T. Role of insulin resistance in MAFLD. Int J Mol Sci. 2021; 22: 4156. Published 2021 Apr 16. doi:10.3390/ijms22084156
- Michalaki MA, Vagenakis AG, Leonardou AS et al. Thyroid function in humans with morbid obesity. Thyroid 2006; 16: 73–78
- Galofre JC, Pujante P, Abreu C et al. Relationship between thyroid-stimulating hormone and insulin in euthyroid obese men. Ann Nutr Metab 2008; 53: 188–194
- Martinez-deMena R, Obregon MJ. Insulin increases the adrenergic stimulation of 5′ deiodinase activity and mRNA expression in rat brown adipocytes; role of MAPK and PI3K. J Mol Endocrinol 2005; 34: 139–151
- Stepanek L, Horakova D, Stepanek L et al. Free triiodothyronine/free thyroxine (FT3/FT4) ratio is strongly associated with insulin resistance in euthyroid and hypothyroid adults: a cross-sectional study. Endokrynol Pol 2021; 72: 8–13
- Malaguarnera R, Vella V, Nicolosi ML et al. Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer? Front Endocrinol (Lausanne) 2017; 8: 314
- Kimura T, Van Keymeulen A, Golstein J et al. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 2001; 22: 631–656
- Vella V, Pandini G, Sciacca L et al. A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab 2002; 87: 245–254
- Wang K, Yang Y, Wu Y et al. The association between insulin resistance and vascularization of thyroid nodules. J Clin Endocrinol Metab 2015; 100: 184–192
- Yu H, Li Q, Zhang M et al. Decreased leptin is associated with alterations in thyroid-stimulating hormone levels after Roux-en-Y gastric bypass surgery in obese euthyroid patients with Type 2 diabetes. Obes Facts 2019; 12: 272–280
- Betry C, Challan-Belval MA, Bernard A et al. Increased TSH in obesity: Evidence for a BMI-independent association with leptin. Diabetes Metab 2015; 41: 248–251
- Schaffler A, Binart N, Scholmerich J et al. Hypothesis paper Brain talks with fat--evidence for a hypothalamic-pituitary-adipose axis? Neuropeptides 2005; 39: 363–367
- Karpuzoglu H, Ucal Y, Kumru P et al. Increased maternal leptin levels may be an indicator of subclinical hypothyroidism in a newborn. J Med Biochem 2022; 41: 156–161
- Araujo RL, Andrade BM, Padron AS et al. High-fat diet increases thyrotropin and oxygen consumption without altering circulating 3,5,3′-triiodothyronine (T3) and thyroxine in rats: the role of iodothyronine deiodinases, reverse T3 production, and whole-body fat oxidation. Endocrinology 2010; 151: 3460–3469
- Araujo RL, Andrade BM, da Silva ML et al. Tissue-specific deiodinase regulation during food restriction and low replacement dose of leptin in rats. Am J Physiol Endocrinol Metab 2009; 296: E1157–1163
- Macek Jilkova Z, Pavelka S, Flachs P et al. Modulation of type I iodothyronine 5′-deiodinase activity in white adipose tissue by nutrition: possible involvement of leptin. Physiol Res 2010; 59: 561–569
- Ghamari-Langroudi M, Vella KR, Srisai D et al. Regulation of thyrotropin-releasing hormone-expressing neurons in paraventricular nucleus of the hypothalamus by signals of adiposity. Mol Endocrinol 2010; 24: 2366–2381
- Nannipieri M, Cecchetti F, Anselmino M et al. Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int J Obes (Lond) 2009; 33: 1001–1006
- Kurylowicz A, Jonas M, Lisik W et al. Obesity is associated with a decrease in expression but not with the hypermethylation of thermogenesis-related genes in adipose tissues. J Transl Med 2015; 13: 31
- Juiz-Valina P, Cordido M, Outeirino-Blanco E et al. Central resistance to thyroid hormones in morbidly obese subjects is reversed after bariatric surgery-induced weight loss. J Clin Med 2020; 9.
- Tjorve E, Tjorve KM, Olsen JO et al. On commonness and rarity of thyroid hormone resistance: a discussion based on mechanisms of reduced sensitivity in peripheral tissues. Med Hypotheses 2007; 69: 913–921
- Laclaustra M, Moreno-Franco B, Lou-Bonafonte JM et al. Impaired sensitivity to thyroid hormones is associated with diabetes and metabolic syndrome. Diabetes Care 2019; 42: 303–310
- Moulin de Moraes CM, Mancini MC, de Melo ME et al. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass. Obes Surg 2005; 15: 1287–1291
- Moreira-Andrés MN, Del Cañizo-Gómez FJ, Black EG, Hoffenberg R. Long-term evaluation of thyroidal response to partial calorie restriction in obesity. Clin Endocrinol (Oxf). 1981;15: 621–626.
- Kaptein EM, Beale E, Chan LS. Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J Clin Endocrinol Metab. 2009; 94: 3663–3675.
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014; 24: 1670–1751.
- Villarroya F, Cereijo R, Villarroya J et al. Brown adipose tissue as a secretory organ. Nat Rev Endocrinol 2017; 13: 26–35
- Bianco AC, Sheng XY, Silva JE. Triiodothyronine amplifies norepinephrine stimulation of uncoupling protein gene transcription by a mechanism not requiring protein synthesis. J Biol Chem 1988; 263: 18168–18175
- Branco M, Ribeiro M, Negrao N et al. 3,5,3′-Triiodothyronine actively stimulates UCP in brown fat under minimal sympathetic activity. Am J Physiol 1999; 276: E179–187
- Silva JE, Larsen PR. Potential of brown adipose tissue type II thyroxine 5′-deiodinase as a local and systemic source of triiodothyronine in rats. J Clin Invest 1985; 76: 2296–2305
- Wang Q, Zhang M, Ning G et al. Brown adipose tissue in humans is activated by elevated plasma catecholamines levels and is inversely related to central obesity. PLoS One 2011; 6: e21006
- Reynisdottir S, Wahrenberg H, Carlstrom K et al. Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors. Diabetologia 1994; 37: 428–435
- Chamberlain PD, Jennings KH, Paul F et al. The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord 1999; 23: 1057–1065
- Valentine JM, Ahmadian M, Keinan O et al. beta3-Adrenergic receptor downregulation leads to adipocyte catecholamine resistance in obesity. J Clin Invest 2022; 132:
- Guo T, Marmol P, Moliner A et al. Adipocyte ALK7 links nutrient overload to catecholamine resistance in obesity. Elife 2014; 3: e03245
- Alcala M, Calderon-Dominguez M, Serra D et al. Mechanisms of Impaired Brown Adipose Tissue Recruitment in Obesity. Front Physiol 2019; 10: 94
- Villarroya F, Cereijo R, Villarroya J et al. Toward an Understanding of How Immune Cells Control Brown and Beige Adipobiology. Cell Metab 2018; 27: 954–961
- Araujo RL, Carvalho DP. Bioenergetic impact of tissue-specific regulation of iodothyronine deiodinases during nutritional imbalance. J Bioenerg Biomembr 2011; 43: 59–65
- de Heredia FP, Gómez-Martínez S, Marcos A. Obesity, inflammation and the immune system. Proc Nutr Soc. 2012; 71: 332–338.
- Deng J, Neff LM, Rubert NC, et al. MRI characterization of brown adipose tissue under thermal challenges in normal weight, overweight, and obese young men. J Magn Reson Imaging. 2018; 47: 936–947. doi:10.1002/jmri.25836
- Kang S, Bajnok L, Longo KA, et al. Effects of Wnt signaling on brown adipocyte differentiation and metabolism mediated by PGC-1alpha. Mol Cell Biol. 2005; 25: 1272–1282. doi:10.1128/MCB.25.4.1272-1282.2005
- Villarroya F, Cereijo R, Gavaldà-Navarro A, Villarroya J, Giralt M. Inflammation of brown/beige adipose tissues in obesity and metabolic disease. J Intern Med. 2018; 284: 492–504.
- Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489–499
- Garmendia Madariaga A, Santos Palacios S, Guillen-Grima F et al. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab 2014; 99: 923–931
- Fierabracci P, Pinchera A, Martinelli S et al. Prevalence of endocrine diseases in morbidly obese patients scheduled for bariatric surgery: beyond diabetes. Obes Surg 2011; 21: 54–60
- Guo X, He Z, Shao S et al. Interaction effect of obesity and thyroid autoimmunity on the prevalence of hyperthyrotropinaemia. Endocrine 2020; 68: 573–583
- Radetti G, Kleon W, Buzi F et al. Thyroid function and structure are affected in childhood obesity. J Clin Endocrinol Metab 2008; 93: 4749–4754
- Rotondi M, Cappelli C, Leporati P et al. A hypoechoic pattern of the thyroid at ultrasound does not indicate autoimmune thyroid diseases in patients with morbid obesity. Eur J Endocrinol 2010; 163: 105–109
- Ittermann T, Markus MR, Schipf S et al. Metformin inhibits goitrogenous effects of type 2 diabetes. Eur J Endocrinol 2013; 169: 9–15
- Belfiore A, Malaguarnera R, Vella V, et al. Insulin receptor isoforms in physiology and disease: An updated view. Endocr Rev. 2017; 38: 379–431. doi:10.1210/er.2017-00073
- Moruzzi N, Lazzeri-Barcelo F. Insulin Receptor Isoforms in Physiology and Metabolic Disease [Internet]. Evolving Concepts in Insulin Resistance. IntechOpen; 2022.
- Leibiger B, Leibiger IB, Moede T, et al. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. Mol Cell. 2001; 7: 559–570.
- Kaminska D, Hämäläinen M, Cederberg H, et al. Adipose tissue INSR splicing in humans associates with fasting insulin level and is regulated by weight loss. Diabetologia. 2014; 57: 347–351.
- Rezzonico JN, Rezzonico M, Pusiol E et al. Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord 2009; 7: 375–380
- Avgerinos KI, Spyrou N, Mantzoros CS et al. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism 2019; 92: 121–135
- Lauby-Secretan B, Scoccianti C, Loomis D et al. Body fatness and cancer--Viewpoint of the IARC Working Group. N Engl J Med 2016; 375: 794–798
- Wang Y, Lin H, Li Q et al. Association between different obesity phenotypes and hypothyroidism: a study based on a longitudinal health management cohort. Endocrine 2021; 72: 688–698
- Nie X, Ma X, Xu Y et al. Characteristics of Serum Thyroid Hormones in Different Metabolic Phenotypes of Obesity. Front Endocrinol (Lausanne) 2020; 11: 68
- Kim JM, Kim BH, Lee H et al. The relationship between thyroid function and different obesity phenotypes in Korean euthyroid adults. Diabetes Metab J 2019; 43: 867–878
- Amouzegar A, Kazemian E, Abdi H et al. Association between thyroid function and development of different obesity phenotypes in euthyroid adults: A nine-year follow-up. Thyroid 2018; 28: 458–464
- Shin JA, Mo EY, Kim ES et al. Association between lower normal free thyroxine concentrations and obesity phenotype in healthy euthyroid subjects. Int J Endocrinol 2014; 2014: 104318
- Amouzegar A, Kazemian E, Abdi H et al. Abdominal Obesity Phenotypes and Incidence of Thyroid Autoimmunity: A 9-Year Follow-up. Endocr Res 2020; 45: 202–209
- Yang H, Xia Q, Shen Y et al. Gender-specific impact of metabolic obesity phenotypes on the risk of Hashimoto's Thyroiditis: A retrospective data analysis using a health check-up database. J Inflamm Res 2022; 15: 827–837
- Zhang C, Gao X, Han Y et al. Correlation Between Thyroid Nodules and Metabolic Syndrome: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2021; 12: 730279
- Zhang F, Li Y, Yu X et al. The Relationship and Gender Disparity Between Thyroid Nodules and Metabolic Syndrome Components Based on a Recent Nationwide Cross-Sectional Study and Meta-Analysis. Front Endocrinol (Lausanne) 2021; 12: 736972
- Guo W, Tan L, Chen W et al. Relationship between metabolic syndrome and thyroid nodules and thyroid volume in an adult population. Endocrine 2019; 65: 357–364
- Xu L, Zeng F, Wang Y et al. Prevalence and associated metabolic factors for thyroid nodules: a cross-sectional study in Southwest of China with more than 120 thousand populations. BMC Endocr Disord 2021; 21: 175
- Song B, Zuo Z, Tan J et al. Association of thyroid nodules with adiposity: a community-based cross-sectional study in China. BMC Endocr Disord 2018; 18: 3
- Su Y, Zhang YL, Zhao M et al. Association between thyroid nodules and volume and metabolic syndrome in an iodine-adequate area: A large community-based population study. Metab Syndr Relat Disord 2019; 17: 217–222
- Son H, Lee H, Kang K et al. The risk of thyroid cancer and obesity: A nationwide population-based study using the Korea National Health Insurance Corporation cohort database. Surg Oncol 2018; 27: 166–171
- Youssef MR, Reisner ASC, Attia AS et al. Obesity and the prevention of thyroid cancer: Impact of body mass index and weight change on developing thyroid cancer - Pooled results of 24 million cohorts. Oral Oncol 2021; 112: 105085
- He Q, Sun H, Li F et al. Obesity and risk of differentiated thyroid cancer: A large-scale case-control study. Clin Endocrinol (Oxf) 2019; 91: 869–878
- Kitahara CM, Pfeiffer RM, Sosa JA et al. Impact of Overweight and Obesity on US Papillary Thyroid Cancer Incidence Trends (1995–2015). J Natl Cancer Inst 2020; 112: 810–817
- Fussey JM, Beaumont RN, Wood AR et al. Does obesity cause thyroid cancer? A Mendelian randomization study. J Clin Endocrinol Metab 2020; 105:
- Rotondi M, Castagna MG, Cappelli C et al. Obesity does not modify the risk of differentiated thyroid cancer in a cytological series of thyroid nodules. Eur Thyroid J 2016; 5: 125–131
- Ahmadi S, Pappa T, Kang AS et al. Point of care measurement of Body Mass Index and thyroid nodule malignancy risk sssessment. Front Endocrinol (Lausanne) 2022; 13: 824226
- Zheng X, Peng R, Xu H et al. The association between metabolic status and risk of cancer among patients with obesity: Metabolically Healthy Obesity vs. Metabolically Unhealthy Obesity. Front Nutr 2022; 9: 783660
- Lin CJ, Chang YC, Cheng TY et al. The association between metabolically healthy obesity and risk of cancer: A systematic review and meta-analysis of prospective cohort studies. Obes Rev 2020; 21: e13049
- Kwon H, Chang Y, Cho A et al. Metabolic obesity phenotypes and thyroid cancer risk: A cohort study. Thyroid 2019; 29: 349–358
- Nguyen DN, Kim JH, Kim MK. Association of metabolic health and central obesity with the risk of thyroid cancer: Data from the Korean Genome and Epidemiology Study. Cancer Epidemiol Biomarkers Prev 2022; 31: 543–553
- Biondi B, Kahaly GJ, Robertson RP. Thyroid dysfunction and diabetes mellitus: Two closely associated disorders. Endocr Rev 2019; 40: 789–824
- Sawicka-Gutaj N, Zybek-Kocik A, Kloska M et al. Effect of restoration of euthyroidism on visfatin concentrations and body composition in women. Endocr Connect 2021; 10: 462–470
- Stangierski A, Ruchala M, Krauze T et al. Treatment of severe thyroid function disorders and changes in body composition. Endokrynol Pol 2016; 67: 359–366
- Jacobsen R, Lundsgaard C, Lorenzen J et al. Subnormal energy expenditure: a putative causal factor in the weight gain induced by treatment of hyperthyroidism. Diabetes Obes Metab 2006; 8: 220–227
- Roef GL, Rietzschel ER, Van Daele CM et al. Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects. Thyroid 2014; 24: 223–231
- Teixeira P, Dos Santos PB, Pazos-Moura CC. The role of thyroid hormone in metabolism and metabolic syndrome. Ther Adv Endocrinol Metab 2020; 11: 2042018820917869
- Bjergved L, Jorgensen T, Perrild H et al. Thyroid function and body weight: a community-based longitudinal study. PLoS One 2014; 9: e93515
- Soriguer F, Valdes S, Morcillo S et al. Thyroid hormone levels predict the change in body weight: a prospective study. Eur J Clin Invest 2011; 41: 1202–1209
- Olszanecka-Glinianowicz M, Chudek J, Szromek A et al. Changes of systemic microinflammation after weight loss and regain - a five-year follow up study. Endokrynol Pol 2012; 63: 432–438
- Khan WF, Singla V, Aggarwal S et al. Outcome of bariatric surgery on hypothyroidism: experience from a tertiary care center in India. Surg Obes Relat Dis 2020; 16: 1297–1301
- Ostrowska L, Gier D, Zysk B. The influence of reducing diets on changes in thyroid parameters in women suffering from obesity and Hashimoto's Disease. Nutrients 2021; 13:
- Fruhbeck G, Busetto L, Dicker D et al. The ABCD of Obesity: An EASO Position Statement on a Diagnostic Term with Clinical and Scientific Implications. Obes Facts 2019; 12: 131–136
- Duntas LH, Biondi B. The interconnections between obesity, thyroid function, and autoimmunity: the multifold role of leptin. Thyroid 2013; 23: 646–653
- Farghaly HS, Metwalley KA, Ahmed FA et al. Visfatin level in children and adolescents with autoimmune thyroiditis. Ther Adv Endocrinol Metab 2017; 8: 119–125
- Sawicka-Gutaj N, Zybek-Kocik A, Klimowicz A et al. Circulating visfatin in hypothyroidism is associated with free thyroid hormones and antithyroperoxidase antibodies. Int J Endocrinol 2016; 2016: 7402469
- Belligoli A, Compagnin C, Sanna M et al. Characterization of subcutaneous and omental adipose tissue in patients with obesity and with different degrees of glucose impairment. Sci Rep 2019; 9: 11333
DOI: https://doi.org/10.2478/ahem-2023-0015 | Journal eISSN: 1732-2693
Language: English
Page range: 107 - 117
Submitted on: May 5, 2023
Accepted on: Aug 3, 2023
Published on: Oct 31, 2023
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
Related subjects:
© 2023 Ewa Malwina Milewska-Kobos, Ewelina Szczepanek-Parulska, Marek Ruchala, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.